Abstracts tagged "population studies and psoriatic arthritis"

Abstract Number: 967 • 2018 ACR/ARHP Annual Meeting
Health Care Utilization for Musculoskeletal Issues during the Pre-Diagnosis Period in Psoriatic Arthritis – a Population-Based Study
Lihi Eder¹, Karen Tu², Cheryl F. Rosen³, Raed Alhusayen⁴, Stephanie Cheng⁵, Jacqueline Young⁵, Willemina Campbell⁶, Sasha Bernatsky⁷, Dafna D Gladman⁸, Richard J. Cook⁹, Michael Paterson⁵ and Jessica Widdifield¹⁰, ¹Women's College Research Institute, University of Toronto, Women's College Hospital, Toronto, ON, Canada, ²Department of Family Medicine, University of Toronto, Toronto, ON, Canada, ³University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ⁴Sunnybrook Research Institute, Sunnybrook Health Sciences Centre, Toronto, ON, Canada, ⁵Institute for Clinical Evaluative Sciences, Toronto, ON, Canada, ⁶Rheumatology, Toronto Western Hospital, Toronto, ON, Canada, ⁷Divisions of Rheumatology and Clinical Epidemiology, The Research Institute of the McGill University Health Centre, Montreal, QC, Canada, ⁸Department of Medicine, Toronto Psoriatic Arthritis Research Program, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, ⁹Statistics and Actuarial Science, University of Waterloo, Waterloo, ON, Canada, ¹⁰University of Toronto, Institute for Clinical Evaluative Sciences, Toronto, ON, Canada
Background/Purpose: Numerous studies have shown delays in diagnosis of psoriatic arthritis (PsA) among patients with psoriasis. The heterogeneous nature and frequently insidious onset of PsA…
Abstract Number: 1697 • 2016 ACR/ARHP Annual Meeting
Validity of Diagnostic Codes and Point Prevalence of Psoriatic Arthritis in Israel – a Population-Based Study
Lihi Eder¹, Arnon Dov Cohen^2,3, Ilan Feldhamer³, Sari Greenberg-Dotan³, Erez Batat³ and Devy Zisman^4,5, ¹Medicine, University of Toronto, Women's College Hospital, Toronto, ON, Canada, ²Siaal Research Center for Family Medicine and Primary Care, Ben-Gurion University of the Negev, Beer-Sheba, Israel, ³Chief Physician's Office, Clalit Health Services, Tel Aviv, Israel, ⁴The Ruth and Bruce Rappaport Faculty of Medicine, Technion, Haifa, Israel, ⁵Department of Rheumatology, Carmel Medical Center, Haifa, Israel
Background/Purpose: The information on the population-based prevalence of Psoriatic Arthritis (PsA) is limited. Large population-based databases provide an opportunity to study the epidemiology of PsA,…
Abstract Number: 1035 • 2013 ACR/ARHP Annual Meeting
Psoriatic Arthritis and Mortality – a Nationwide Study
Thorvardur Jon Love^1,2, Thor Aspelund³, Alexis Ogdie⁴, Joel M. Gelfand⁵, Hyon K. Choi⁶, Vilmundur Gudnason³ and Bjorn Gudbjornsson², ¹Landspitali University Hospital, Reykjavik, Iceland, ²Faculty of Medicine, University of Iceland, Reykjavik, Iceland, ³The Icelandic Heart Association, Kopavogur, Iceland, ⁴Rheumatology and Epidemiology, University of Pennsylvania, Philadelphia, PA, ⁵University of Pennsylvania., Philadelphia, PA, ⁶Section of Rheumatology and the Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA
Background/Purpose: Psoriatic arthritis is an inflammatory arthritis that causes significant morbidity. While a study from a single research clinic in Canada published in the 1990´s…
Abstract Number: 1036 • 2013 ACR/ARHP Annual Meeting
The Independent Impact Of Depression On Incident Myocardial Infarction In Psoriatic Disease: A Population-Based Cohort Study
Lindsay C Burns^1,2, Jan P. Dutz¹ and Hyon Choi^3,4,5, ¹Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada, ²Research, Arthritis Research Centre of Canada, Richmond, BC, Canada, ³Arthritis Research Centre of Canada, Richmond, BC, Canada, ⁴Section of Rheumatology and the Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA, ⁵Division of Rheumatology, Allergy, and Immunology Massachusetts General Hospital, Harvard Medical School, Boston, MA
Background/Purpose: Psoriasis (PsC) and psoriatic arthritis (PsA) represent common, lifelong inflammatory diseases of the skin and joints (respectively) that are associated with substantial cardiovascular and…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].